Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
tolimidone (MTX228) / Bukwang Pharma, Biodexa Pharma
NCT06474598: An Adaptive Design Study of MTX228	Not yet recruiting	2	24	NA	MTX228, Tolimidone, DEXCOM G6	University of Alberta	Type 1 Diabetes Mellitus	10/26	12/27